Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 22,072,000 | 14,598,000 | 10,049,000 | 8,288,000 | 8,643,000 |
| Depreciation Amortization | 6,410,000 | 7,655,000 | 9,026,000 | 8,399,000 | 4,757,000 |
| Income taxes - deferred | 1,703,000 | 2,198,000 | 454,000 | 1,953,000 | -9,582,000 |
| Accounts receivable | 940,000 | 367,000 | 140,000 | -608,000 | 252,000 |
| Other Working Capital | -3,378,000 | -2,367,000 | 2,533,000 | -10,362,000 | 11,987,000 |
| Other Operating Activity | -10,063,000 | -5,705,000 | -1,962,000 | 3,784,000 | 530,000 |
| Operating Cash Flow | $17,684,000 | $16,746,000 | $20,240,000 | $11,454,000 | $16,587,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -5,911,000 | 2,743,000 | 6,603,000 | 567,000 | 12,808,000 |
| PPE Investments | -1,206,000 | -1,327,000 | -1,660,000 | -1,513,000 | -1,205,000 |
| Net Acquisitions | -15,000 | 10,800,000 | -906,000 | -273,000 | -43,123,000 |
| Purchase Of Investment | -11,020,000 | -11,145,000 | -4,620,000 | -4,128,000 | -6,888,000 |
| Sale Of Investment | 7,555,000 | 4,990,000 | 2,147,000 | 4,737,000 | 6,504,000 |
| Purchase Sale Intangibles | -259,000 | -92,000 | -222,000 | N/A | N/A |
| Other Investing Activity | 53,000 | 93,000 | 279,000 | 118,000 | 632,000 |
| Investing Cash Flow | $-10,544,000 | $6,154,000 | $1,843,000 | $-492,000 | $-31,272,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 7,798,000 | 7,965,000 | 14,720,000 | 5,103,000 | 32,033,000 |
| Debt Issued | 6,618,000 | N/A | N/A | N/A | 24,023,000 |
| Debt Repayment | -4,146,000 | -1,513,000 | -6,986,000 | -6,000 | -967,000 |
| Common Stock Issued | 1,750,000 | 568,000 | 153,000 | N/A | N/A |
| Common Stock Repurchased | -16,290,000 | -8,228,000 | -9,000,000 | -1,000,000 | N/A |
| Dividend Paid | -6,580,000 | -6,534,000 | -6,234,000 | -6,088,000 | -5,548,000 |
| Other Financing Activity | -4,125,000 | -8,257,000 | -13,260,000 | -9,183,000 | -35,060,000 |
| Financing Cash Flow | $-14,975,000 | $-15,999,000 | $-20,607,000 | $-11,174,000 | $14,481,000 |
| Exchange Rate Effect | -63,000 | -2,000 | -29,000 | -31,000 | 60,000 |
| Beginning Cash Position | 10,081,000 | 3,182,000 | 1,735,000 | 1,978,000 | 2,122,000 |
| End Cash Position | 2,183,000 | 10,081,000 | 3,182,000 | 1,735,000 | 1,978,000 |
| Net Cash Flow | $-7,898,000 | $6,899,000 | $1,447,000 | $-243,000 | $-144,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 17,684,000 | 16,746,000 | 20,240,000 | 11,454,000 | 16,587,000 |
| Capital Expenditure | -1,206,000 | -1,327,000 | -1,660,000 | -1,513,000 | -1,205,000 |
| Free Cash Flow | 16,478,000 | 15,419,000 | 18,580,000 | 9,941,000 | 15,382,000 |